Ceva Animal Health expanding into swine market

Craig Wallace

Ceva Animal Health, which develops and produces vaccines primarily for the poultry industry, is expanding into the swine market. Earlier this year the company announced it was entering the equine market.

The two new divisions come as Ceva completed its 2013 acquisition of companion animal health company Sogeval Laboratories, the Kansas City Business Journal reported. Ceva's North American headquarters are located in Lenexa, KS.

"The vision for this has been in the works for probably 10 years," Craig Wallace, the company's director of North America operations, told the Business Journal. "And we have been talking about the personnel side and infrastructure needs to enter the market since 2011. We've really started accelerating that process."

Last month, the company committed to spending $8.3 million to expand its U.S. operations and beef up its Lenexa facility. In 2005, Ceva bought Biomune and spent $7 million on expanding that company's former R&D facility.

Ceva Animal Health is the American branch of Ceva Sante Animale, which was founded in 1999, when the former Sanofi-Aventis subsidiary completed the first of four leveraged buyouts. Ceva Sante Animale is based out of Libourne, France.

- here's the KCBJ story

Special Report: Top 10 animal health companies of 2013 - Ceva Animal Health

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…